Allezoe Medical (ALZM) is the holding company for Organ Transport Systems, Inc. and for future acquisitions targeted to medical products, solutions and services.
Organ Transport Systems, is a biomedical company engaged in developing, patenting, and commercializing portable hypothermic, oxygenated preservation and transport technology for human organs. OTS plans to redefine human organ transplantation through better preservation with its LifeCradle product line.
Organ Transport Systems ("OTS") is focused on improving human donor organ procurement though better organ preservation technology, with its Life Cradle Product Line. As a result of factors including shortcomings in the currently available preservation and transport methods, a low percentage of donated organs are actually utilized. By providing a safe and cost effective method to transport human organs for transplant purposes, OTS hopes to increase the percentage of donated organs that are utilized in transplantation.
Current statistics show that only 27% of donated hearts and only 9% of donated lungs actually can be transplanted for various reasons, many of which OTS addresses with its medical devices. The OTS LifeCradle technology has already been shown in pre-clinical studies to significantly increase preservation time and improve the condition of transplanted animal hearts compared with the current systems in use.
ALZM Investor Highlights
Announced that Orgarn Transport Systems is preparing for clinical trials of its LifeCradle and that the company plans to begin with applications of its technology to donor heart preservation. Organ Transport Systems is a wholly-owned subsidiary of Allezoe.
Announced that it has acquired Organ Transport Systems, Inc. (OTS) from Healthcare of Today, Inc. in an all stock transaction.
The acquisition of OTS is the first of several planned acquisitions by Allezoe Medical Holdings ("Allezoe") in the medical device development, manufacturing and related services market.
Current statistics show that only 27% of donated hearts and only 9% of donated lungs actually can be transplanted for various reasons, many of which OTS addresses with its medical devices. The OTS LifeCradle technology has already been shown in pre-clinical studies to significantly increase preservation time and improve the condition of transplanted animal hearts compared with the current systems in use.
Announced that Gene A. Pierce will join the Organ Transports Systems Board of Advisors. OTS is a wholly-owned subsidiary of Allezoe. Mr. Pierce is the Founder and Executive Director emeritus of United Network For Organ sharing (UNOS) and Southeast Organ Procurement, he is also widely hailed as the patriarch of organ sharing. In addition to his groundbreaking work creating the UNOS network, Mr. Pierce is the recipient of two honorary doctorates as well as several distinguished awards throughout his military and civilian careers.
Mr. Pierce says, "There are tremendous opportunities to improve the preservation and transportation of donated organs. OTS has developed impressive technologies and with their collaborating research scientists have documented outstanding results in their pre-clinical animal studies. The implementation of these technologies in the real clinical setting will greatly advance the field for organ procurement organizations, transplant surgical teams, and most of all patient recipients."
To learn more about ALZM visit http://www.smallcapreview.com/alzm.htm.
Features available at SmallCapReview.com include in-depth profiles of select Small-Cap/Penny Stocks as well as the most comprehensive and up to date news available on the small-cap market.
No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. Nothing within our site should be construed as an offer or solicitation to buy or sell products or securities. The companies we profile may lack an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. SmallCapReview.com has been compensated three thousand five hundred dollars by a third party Winning Media for its services with regards to Allezoe Medical.
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. A news service of SCR, 2312 Healy Dr., Winston-Salem, NC 27107. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit http://www.smallcapreview.com.
